Last reviewed · How we verify
intermittent fentanyl infusion
Intermittent fentanyl infusion delivers the opioid fentanyl in periodic doses to provide pain relief while potentially reducing continuous exposure.
Intermittent fentanyl infusion delivers the opioid fentanyl in periodic doses to provide pain relief while potentially reducing continuous exposure. Used for Acute postoperative pain, Acute pain in hospitalized patients.
At a glance
| Generic name | intermittent fentanyl infusion |
|---|---|
| Sponsor | Kaohsiung Veterans General Hospital. |
| Drug class | Opioid agonist |
| Target | Mu-opioid receptor (OPRM1) |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | FDA-approved |
Mechanism of action
Fentanyl is a potent synthetic opioid agonist that binds to mu-opioid receptors in the central and peripheral nervous system to modulate pain perception and transmission. Intermittent infusion (as opposed to continuous infusion) administers fentanyl in scheduled intervals, which may help balance analgesia with reduced side effects from sustained high drug levels. This dosing approach is typically used in acute or perioperative pain management settings.
Approved indications
- Acute postoperative pain
- Acute pain in hospitalized patients
Common side effects
- Respiratory depression
- Sedation
- Nausea
- Hypotension
- Pruritus
Key clinical trials
- Comparing PIEB and CEI for Labor Pain Relief (NA)
- Effect of Dexmedetomidine on Tear Production in Angioplasty Patients (NA)
- SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke (PHASE4)
- Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies (NA)
- GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (PHASE3)
- Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes (NA)
- Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery (NA)
- Analgesia-First Sedation in Trauma Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |